Sökning: WFRF:(Denton C. P.) > Predictors of disea...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08073naa a2202233 4500 | |
001 | oai:prod.swepub.kib.ki.se:141896739 | |
003 | SwePub | |
008 | 240825s2019 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1418967392 URI |
024 | 7 | a https://doi.org/10.1136/annrheumdis-2019-2151452 DOI |
040 | a (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Becker, M4 aut |
245 | 1 0 | a Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis |
264 | c 2019-06-21 | |
264 | 1 | b BMJ,c 2019 |
520 | a Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Research group database.MethodsInclusion criteria were diagnosis of diffuse SSc and follow-up over 12±3 months. Disease worsening/organ progression was fulfilled if any of the following events occurred: new renal crisis; decrease of lung or heart function; new echocardiography-suspected pulmonary hypertension or death. In total, 42 clinical parameters were chosen as predictors for the analysis by using (1) imputation of missing data on the basis of multivariate imputation and (2) least absolute shrinkage and selection operator regression.ResultsOf 1451 patients meeting the inclusion criteria, 706 had complete data on outcome parameters and were included in the analysis. Of the 42 outcome predictors, eight remained in the final regression model. There was substantial evidence for a strong association between disease progression and age, active digital ulcer (DU), lung fibrosis, muscle weakness and elevated C-reactive protein (CRP) level. Active DU, CRP elevation, lung fibrosis and muscle weakness were also associated with a significantly shorter time to disease progression. A bootstrap validation step with 10 000 repetitions successfully validated the model.ConclusionsThe use of the predictive factors presented here could enable cohort enrichment with patients at risk for overall disease worsening in SSc clinical trials. | |
700 | 1 | a Graf, N4 aut |
700 | 1 | a Sauter, R4 aut |
700 | 1 | a Allanore, Y4 aut |
700 | 1 | a Curram, J4 aut |
700 | 1 | a Denton, CP4 aut |
700 | 1 | a Khanna, D4 aut |
700 | 1 | a Matucci-Cerinic, M4 aut |
700 | 1 | a Pena, JD4 aut |
700 | 1 | a Pope, JE4 aut |
700 | 1 | a Distler, O4 aut |
700 | 1 | a Matucci-Cerinic, M4 aut |
700 | 1 | a Guiducci, S4 aut |
700 | 1 | a Walker, U4 aut |
700 | 1 | a Jaeger, V4 aut |
700 | 1 | a Bannert, B4 aut |
700 | 1 | a Lapadula, G4 aut |
700 | 1 | a Becvarare, R4 aut |
700 | 1 | a Cutolo, M4 aut |
700 | 1 | a Valentini, G4 aut |
700 | 1 | a Siegert, E4 aut |
700 | 1 | a Rednic, S4 aut |
700 | 1 | a Allanore, Y4 aut |
700 | 1 | a Montecucco, C4 aut |
700 | 1 | a Carreira, PE4 aut |
700 | 1 | a Novak, S4 aut |
700 | 1 | a Czirjak, L4 aut |
700 | 1 | a Varju, C4 aut |
700 | 1 | a Chizzolini, C4 aut |
700 | 1 | a Allai, D4 aut |
700 | 1 | a Kucharz, EJ4 aut |
700 | 1 | a Cozzi, F4 aut |
700 | 1 | a Rozman, B4 aut |
700 | 1 | a Mallia, C4 aut |
700 | 1 | a Gabrielli, A4 aut |
700 | 1 | a Bancel, DF4 aut |
700 | 1 | a Airo, P4 aut |
700 | 1 | a Hesselstrand, R4 aut |
700 | 1 | a Martinovic, D4 aut |
700 | 1 | a Balbir-Gurman, A4 aut |
700 | 1 | a Braun-Moscovici, Y4 aut |
700 | 1 | a Hunzelmann, N4 aut |
700 | 1 | a Pellerito, R4 aut |
700 | 1 | a Caramaschi, P4 aut |
700 | 1 | a Black, C4 aut |
700 | 1 | a Damjanov, N4 aut |
700 | 1 | a Henes, J4 aut |
700 | 1 | a Santamaria, VO4 aut |
700 | 1 | a Heitmann, S4 aut |
700 | 1 | a Seidel, M4 aut |
700 | 1 | a Da Silva, JAP4 aut |
700 | 1 | a Stamenkovic, B4 aut |
700 | 1 | a Selmi, CF4 aut |
700 | 1 | a Tikly, M4 aut |
700 | 1 | a Denisov, LN4 aut |
700 | 1 | a Muller-Ladner, U4 aut |
700 | 1 | a Engelhart, M4 aut |
700 | 1 | a Hachulla, E4 aut |
700 | 1 | a Riccieri, V4 aut |
700 | 1 | a Ionescu, RM4 aut |
700 | 1 | a Mihai, C4 aut |
700 | 1 | a Sunderkotter, C4 aut |
700 | 1 | a Kuhn, A4 aut |
700 | 1 | a Schett, G4 aut |
700 | 1 | a Distler, J4 aut |
700 | 1 | a Meroni, P4 aut |
700 | 1 | a Ingegnoli, F4 aut |
700 | 1 | a Mouthon, L4 aut |
700 | 1 | a De Keyser, F4 aut |
700 | 1 | a Smith, V4 aut |
700 | 1 | a Cantatore, FP4 aut |
700 | 1 | a Corrado, A4 aut |
700 | 1 | a Ullman, S4 aut |
700 | 1 | a Iversen, L4 aut |
700 | 1 | a Pozzi, MR4 aut |
700 | 1 | a Eyerich, Ku Karolinska Institutet4 aut |
700 | 1 | a Hein, R4 aut |
700 | 1 | a Knott, E4 aut |
700 | 1 | a Wiland, P4 aut |
700 | 1 | a Szmyrka-Kaczmarek, M4 aut |
700 | 1 | a Sokolik, R4 aut |
700 | 1 | a Morgiel, E4 aut |
700 | 1 | a Madej, M4 aut |
700 | 1 | a Alegre-Sancho, JJ4 aut |
700 | 1 | a Krummel-Lorenz, B4 aut |
700 | 1 | a Saar, P4 aut |
700 | 1 | a Aringer, M4 aut |
700 | 1 | a Gunther, C4 aut |
700 | 1 | a Anne, E4 aut |
700 | 1 | a Westhovens, R4 aut |
700 | 1 | a De Langhe, E4 aut |
700 | 1 | a Lenaerts, J4 aut |
700 | 1 | a Anic, B4 aut |
700 | 1 | a Baresic, M4 aut |
700 | 1 | a Mayer, M4 aut |
700 | 1 | a Uprus, M4 aut |
700 | 1 | a Otsa, K4 aut |
700 | 1 | a Yavuz, S4 aut |
700 | 1 | a Radominski, SC4 aut |
700 | 1 | a Muller, CD4 aut |
700 | 1 | a Azevedo, VF4 aut |
700 | 1 | a Popa, S4 aut |
700 | 1 | a Zenone, T4 aut |
700 | 1 | a Stebbings, S4 aut |
700 | 1 | a Highton, J4 aut |
700 | 1 | a Mathieu, A4 aut |
700 | 1 | a Vacca, A4 aut |
700 | 1 | a Stamp, L4 aut |
700 | 1 | a Chapman, P4 aut |
700 | 1 | a O'Donnell, J4 aut |
700 | 1 | a Solanki, K4 aut |
700 | 1 | a Doube, A4 aut |
700 | 1 | a Veale, D4 aut |
700 | 1 | a O'Rourke, M4 aut |
700 | 1 | a Loyo, E4 aut |
700 | 1 | a Li, MT4 aut |
700 | 1 | a Rosato, E4 aut |
700 | 1 | a Amoroso, A4 aut |
700 | 1 | a Gigante, A4 aut |
700 | 1 | a Oksel, F4 aut |
700 | 1 | a Yargucu, F4 aut |
700 | 1 | a Tanaseanu, CM4 aut |
700 | 1 | a Popescu, M4 aut |
700 | 1 | a Dumitrascu, A4 aut |
700 | 1 | a Tiglea, I4 aut |
700 | 1 | a Foti, R4 aut |
700 | 1 | a Visalli, E4 aut |
700 | 1 | a Benenati, A4 aut |
700 | 1 | a Amato, G4 aut |
700 | 1 | a Ancuta, C4 aut |
700 | 1 | a Chirieac, R4 aut |
700 | 1 | a Villiger, P4 aut |
700 | 1 | a Adler, S4 aut |
700 | 1 | a Dan, D4 aut |
700 | 1 | a Lefebvre, PGD4 aut |
700 | 1 | a Rubio, SR4 aut |
700 | 1 | a Exposito, MV4 aut |
700 | 1 | a Sibilia, J4 aut |
700 | 1 | a Chatelus, E4 aut |
700 | 1 | a Gottenberg, JE4 aut |
700 | 1 | a Chifflot, H4 aut |
700 | 1 | a Litinsky, I4 aut |
700 | 1 | a Del Galdo, F4 aut |
700 | 1 | a Venalis, A4 aut |
700 | 1 | a Saketkoo, LA4 aut |
700 | 1 | a Lasky, JA4 aut |
700 | 1 | a Kerzberg, E4 aut |
700 | 1 | a Montoya, F4 aut |
700 | 1 | a Cosentino, V4 aut |
700 | 1 | a Limonta, M4 aut |
700 | 1 | a Brucato, AL4 aut |
700 | 1 | a Lupi, E4 aut |
700 | 1 | a Spertini, F4 aut |
700 | 1 | a Ribi, C4 aut |
700 | 1 | a Buss, G4 aut |
700 | 1 | a Martin, T4 aut |
700 | 1 | a Guffroy, A4 aut |
700 | 1 | a Poindron, V4 aut |
700 | 1 | a Chung, L4 aut |
700 | 1 | a Schmeiser, T4 aut |
700 | 1 | a Zebryk, P4 aut |
700 | 1 | a Riso, N4 aut |
700 | 1 | a Riemekasten, G4 aut |
700 | 1 | a Rezus, E4 aut |
700 | 1 | a Puttini, PS4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Annals of the rheumatic diseasesd : BMJg 78:9, s. 1242-1248q 78:9<1242-1248x 1468-2060x 0003-4967 |
856 | 4 | u https://ard.bmj.com/content/annrheumdis/78/9/1242.full.pdf |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:141896739 |
856 | 4 8 | u https://doi.org/10.1136/annrheumdis-2019-215145 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.